Selective suppression of pathologic, but not physiologic, retinal neovascularization by blocking the angiotensin II type 1 receptor.
Nagai N, Noda K, Urano T, Kubota Y, Shinoda H, Koto T, Shinoda K, Inoue M, Shiomi T, Ikeda E, Tsubota K, Suda T, Oike Y, Ishida S.
Nagai N, et al. Among authors: shinoda k, shinoda h.
Invest Ophthalmol Vis Sci. 2005 Mar;46(3):1078-84. doi: 10.1167/iovs.04-1101.
Invest Ophthalmol Vis Sci. 2005.
PMID: 15728568